| First Author | Semeniak D | Year | 2016 |
| Journal | J Cell Sci | Volume | 129 |
| Issue | 18 | Pages | 3473-84 |
| PubMed ID | 27505889 | Mgi Jnum | J:246349 |
| Mgi Id | MGI:5923895 | Doi | 10.1242/jcs.187971 |
| Citation | Semeniak D, et al. (2016) Proplatelet formation is selectively inhibited by collagen type I through Syk-independent GPVI signaling. J Cell Sci 129(18):3473-84 |
| abstractText | Collagen receptors GPVI (also known as GP6) and integrin alpha2beta1 are highly expressed on blood platelets and megakaryocytes, their immediate precursors. After vessel injury, subendothelial collagen becomes exposed and induces platelet activation to prevent blood loss. Collagen types I and IV are thought to have opposite effects on platelet biogenesis, directing proplatelet formation (PPF) towards the blood vessels to prevent premature release within the marrow cavity. We used megakaryocytes lacking collagen receptors or treated megakaryocytes with blocking antibodies, and could demonstrate that collagen-I-mediated inhibition of PPF is specifically controlled by GPVI. Other collagen types competed for binding and diminished the inhibitory signal, which was entirely dependent on receptor-proximal Src family kinases, whereas Syk and LAT were dispensable. Adhesion assays indicate that megakaryocyte binding to collagens is mediated by alpha2beta1, and that collagen IV at the vascular niche might displace collagen I from megakaryocytes and thus contribute to prevention of premature platelet release into the marrow cavity and thereby directionally promote PPF at the vasculature. |
